- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Aditya Birla Sun Life MNC Fund vs UTI MNC Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2 | 2.03 |
NAV | ₹1380.87 | ₹390.61 |
Fund Started | 12 Apr 1994 | 01 Aug 2005 |
Fund Size | ₹3671.76 Cr | ₹2792.68 Cr |
Exit Load | Exit load of 1%, if redeemed within 90 days. | Exit load of 1% if redeemed less than 1 year |
Risk
Very High
Very High
Rating
-
-
Min SIP Amount
₹100
₹500
Expense Ratio
2
2.03
NAV
₹1380.87
₹390.61
Fund Started
12 Apr 1994
01 Aug 2005
Fund Size
₹3671.76 Cr
₹2792.68 Cr
Exit Load
Exit load of 1%, if redeemed within 90 days.
Exit load of 1% if redeemed less than 1 year
Returns
1 Year | -0.94% | -3.33% |
3 Year | 16.58% | 15.48% |
5 Year | 13.45% | 15.33% |
1 Year
-0.94%
-3.33%
3 Year
16.58%
15.48%
5 Year
13.45%
15.33%
Holding Analysis
Equity | 98.77% | 94.95% |
Cash | 1.23% | 4.65% |
Equity
98.77%
94.95%
Cash
1.23%
4.65%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 5.51% |
Schaeffler India Ltd. | 4.05% |
Bayer CropScience Ltd. | 3.99% |
United Breweries Ltd. | 3.53% |
Hindustan Unilever Ltd. | 3.23% |
Cummins India Ltd. | 3.18% |
Honeywell Automation India Ltd. | 3.03% |
ICRA Ltd. | 3.02% |
United Spirits Ltd. | 2.97% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.85% |
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 8.97% |
Nestle India Ltd. | 5.52% |
Procter & Gamble Health Ltd. | 4.96% |
United Spirits Ltd. | 4.27% |
Vedanta Ltd. | 4.03% |
Hindustan Unilever Ltd. | 3.68% |
Britannia Industries Ltd. | 3.35% |
3M India Ltd. | 2.93% |
Procter & Gamble Hygiene and Health Care Ltd. | 2.53% |
Gland Pharma Ltd. | 2.42% |
Fund Manager
Name | Dhaval Joshi | Karthikraj Lakshmanan |
Start Date | 21 Nov 2022 | 16 Nov 2022 |
Name
Dhaval Joshi
Karthikraj Lakshmanan
Start Date
21 Nov 2022
16 Nov 2022
About Fund
Description | The scheme would invest exclusively in securities of multinational companies in order to achieve long term growth of capital at relatively moderate levels of risk. A portion of the fund will also be invested in IPO and other primary market offerings. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies. |
Launch Date | 12 Apr 1994 | 01 Aug 2005 |
Description
The scheme would invest exclusively in securities of multinational companies in order to achieve long term growth of capital at relatively moderate levels of risk. A portion of the fund will also be invested in IPO and other primary market offerings.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies.
Launch Date
12 Apr 1994
01 Aug 2005